Samsung tackles biopharma space in JV with Quintiles
To facilitate Samsung Electronics Co. Ltd.’s entry into the biopharma industry, the appliance and electronics maker has created a joint venture with Quintiles Transnational Corp. (clinical trials, marketing, and consulting services) that will provide contract manufacturing of biosimilars in South Korea.
- Contract Research Organization-CRO
- Large Molecule
- Includes Equity
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.